How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
about
Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal womenAdjuvant Gonadotropin-releasing hormone analogues for chemotherapy induced premature ovarian failure in premenopausal womenPremature ovarian insufficiency: Pathogenesis and managementStrategies for fertility preservation in young patients with cancer: a comprehensive approachPrevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.GnRH agonist therapy to protect ovarian function in young Korean breast cancer patientsFertility Preservation for Prepubertal Girls: Update and Current ChallengesThe risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat.Fertility preservationThe feasibility and efficacy of gonadotropin-releasing hormone agonists for prevention of chemotherapy induced ovarian failure in patient with gynecological malignanciesAdverse obstetric and perinatal outcomes following treatment of adolescent and young adult cancer: a population-based cohort studyFertility preservation in women with cancer.Preserving female fertility following cancer treatment: current options and future possibilitiesResults from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer.Fertility preservation in female cancer patients: An overview.Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist treatmentGonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis.Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes.Applicability of adult techniques for ovarian preservation to childhood cancer patients.Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis.Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in SurvivorsCancer and fertility preservation: fertility preservation in breast cancer patients.Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.Hormonal suppression for fertility preservation in males and femalesBreast cancer in young women and its impact on reproductive functionCharacterization of the gonadotropin releasing hormone receptor (GnRHR) expression and activity in the female mouse ovary.Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.Addressing fertility needs of breast cancer patients: oncology perspective.Multidrug-resistant transport activity protects oocytes from chemotherapeutic agents and changes during oocyte maturationGnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.Oncofertility in Canada: gonadal protection and fertility-sparing strategies.Orthotopic and heterotopic ovarian tissue transplantation.Fertility preservation in gynecological cancers.LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse.Fertility-preservation in endometrial cancer: is it safe? Review of the literature.Oncofertility program implementation increases access to fertility preservation options and assisted reproductive procedures for breast cancer patients.Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning
P2860
Q24235150-F22163C3-AFA6-4111-BFA2-0E286CE213D1Q24241143-DC15D1A0-A6FE-4801-95A5-042C4742A072Q26768249-EDEBAF1C-D3E2-44F5-AEF0-DD7BFCECB5CDQ27002719-202AB1D0-D8AB-479D-8BEF-F5BB49CFD128Q28240178-EA1D4F31-DB29-45A9-B285-B52573AABDE3Q30360464-078DC713-B84B-4F88-BE89-D32A7130BE70Q33565544-F2519CA0-8F8A-43EE-8744-6BBEDB2EC255Q34015324-4AEE5849-EE52-4389-BD8F-797564CE3312Q34277890-92EB4FC6-73A2-403B-881A-327E5641E4DDQ34370266-B9501213-8B15-437A-8F96-BAF6664B0857Q34450948-30675875-63BC-4EB0-AA4A-652586F538D3Q34577007-B193DBB8-B7AA-4476-92D3-ECBEEB599632Q34653591-B3C6F612-D411-40FC-9217-234C7589F87DQ34729392-F11EBB9A-27CE-4250-93D4-A013C16DFEF2Q34847120-F3B1959C-70D9-4584-83ED-73EA79E630B3Q34861840-6C29F95A-5A93-44D0-AD92-2A2601B52657Q35237851-A9EA4BA9-C1FD-44D1-B3DE-DD725C426B78Q35583657-22C84C3B-C1E2-4DA6-A1BB-159C44F548FFQ35776206-98297547-E223-4329-BCBE-79E945B08065Q35856600-C0E64CD7-9984-457E-8E5D-87357BB03F37Q35946314-F67374BA-1D39-423D-A8EF-C887C7A40A09Q36295588-68AC4DCF-3AEB-4A35-B56E-C5F55BE03297Q36404774-2D4321B8-5D57-4C77-B3A9-077801F4DE8BQ36478738-02433AC8-4377-4D5F-87FD-97AB370EE886Q36678693-32B75063-A606-4457-B7C1-0838CEC2B7B2Q36688597-1C7BD557-949C-4DF2-B3C2-C1018CF0EFE7Q37019526-3D5DB5CC-5900-4DF1-8D24-27CEF5BD26D5Q37153908-E3F44478-B373-4F24-B0C2-8539E207E0FDQ37181877-7BCF3774-967F-43F7-AD83-F4680D7AFD80Q37213101-501928B9-2D3E-4539-81CB-01F2E049D17CQ37242682-84CDBC25-B017-4FB4-A57B-66D188B9B60BQ37281939-14D32347-2514-4BEE-A0C9-3833F3F2D38EQ37282095-17D901BF-84B1-442F-A9E3-DC6C45E6B0F7Q37364626-E7B173B6-833B-4F9A-9F59-BE6DD06806DAQ37381041-8E88BBE4-1794-4A02-9C99-38E9BDFBFD5DQ37463014-75949736-1220-4CFD-8FD8-F7A508C8F369Q37602870-BE4432F2-804D-4556-AE65-1BC757CD74D9Q37605349-5EADB424-414C-4809-9B43-8524E8719D77Q37625041-2ED3CFB6-0E0F-4A2E-ADD6-75DF108D87FCQ37633480-D627B9A0-9611-414E-949C-2B6BC365DD11
P2860
How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
How to preserve fertility in y ...... f embrya, oocytes, or ovaries.
@en
type
label
How to preserve fertility in y ...... f embrya, oocytes, or ovaries.
@en
prefLabel
How to preserve fertility in y ...... f embrya, oocytes, or ovaries.
@en
P1433
P1476
How to preserve fertility in y ...... f embrya, oocytes, or ovaries.
@en
P2093
Zeev Blumenfeld
P304
P356
10.1634/THEONCOLOGIST.12-9-1044
P577
2007-09-01T00:00:00Z